Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1984 6
1985 1
1986 5
1988 2
1989 1
1991 1
2003 1
2006 2
2007 1
2011 1
2012 1
2013 1
2014 2
2015 3
2016 2
2017 6
2018 4
2019 2
2020 4
2021 4
2022 7
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Tomita Y, Kamide Y, Tsuburai T, Sekiya K, Ishii M, Hasegawa Y, Taniguchi M. Hayashi H, et al. Among authors: watai k. J Allergy Clin Immunol. 2023 Jun;151(6):1667-1672.e2. doi: 10.1016/j.jaci.2023.03.014. Epub 2023 Mar 24. J Allergy Clin Immunol. 2023. PMID: 36967017 Free article. Clinical Trial.
Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis.
Okada N, Yamamoto Y, Oguma T, Tanaka J, Tomomatsu K, Shiraishi Y, Matsuse H, Shimoda T, Kimura H, Watai K, Harada T, Fujita Y, Obase Y, Suzukawa M, Suzuki J, Takayanagi N, Ishiguro T, Masaki K, Fukunaga K, Asano K. Okada N, et al. Among authors: watai k. Allergy. 2023 Nov;78(11):2933-2943. doi: 10.1111/all.15820. Epub 2023 Jul 17. Allergy. 2023. PMID: 37458287
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
Taniguchi M, Mitsui C, Hayashi H, Ono E, Kajiwara K, Mita H, Watai K, Kamide Y, Fukutomi Y, Sekiya K, Higashi N. Taniguchi M, et al. Among authors: watai k. Allergol Int. 2019 Jul;68(3):289-295. doi: 10.1016/j.alit.2019.05.001. Epub 2019 Jun 21. Allergol Int. 2019. PMID: 31235242 Free article. Review.
[EOSINOPHILIC GRANULOMATOSIS WITH POLYANGITIS (EGPA)].
Taniguchi M, Sekiya K, Kamide Y, Fukutomi Y, Watai K, Hamada Y, Nakamura Y, Ryu K, Fujita N, Yano K, Iwata M, Nagayama K, Mori A. Taniguchi M, et al. Among authors: watai k. Arerugi. 2020;69(5):293-303. doi: 10.15036/arerugi.69.293. Arerugi. 2020. PMID: 32684542 Japanese. No abstract available.
Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells: Implication of a Potential Drug-ADC Interaction in Cancer Chemotherapy.
Kiyomiya K, Tomabechi R, Saito N, Watai K, Takada T, Shirasaka Y, Kishimoto H, Higuchi K, Inoue K. Kiyomiya K, et al. Among authors: watai k. Mol Pharm. 2023 Dec 4;20(12):6130-6139. doi: 10.1021/acs.molpharmaceut.3c00490. Epub 2023 Nov 16. Mol Pharm. 2023. PMID: 37971309
[Steroid resistance of severe asthma - mechanisms and therapeutic targets].
Mori A, Kouyama S, Ohtomo-Abe A, Yamaguchi M, Kumitani C, Iwamoto K, Yano K, Fujita N, Iwata M, Nagayama K, Ryu K, Nakamura Y, Hamada Y, Watai K, Kamide Y, Sekiya K, Fukutomi Y, Matsumoto K, Tanimoto Y, Kobayashi N, Ohtomo T, Kaminuma O. Mori A, et al. Among authors: watai k. Nihon Yakurigaku Zasshi. 2022;157(5):293-298. doi: 10.1254/fpj.22027. Nihon Yakurigaku Zasshi. 2022. PMID: 36047138 Clinical Trial. Japanese.
62 results